vimarsana.com
Home
Live Updates
Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance : vimarsana.com
Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance
/PRNewswire/ -- Asieris Pharmaceuticals (688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs...
Related Keywords
Lecheng ,
Hainan ,
China ,
Norway ,
Taiwan ,
Shanghai ,
United States ,
Oslo ,
Chinese ,
Xinming Jiang ,
Security Bureau Of Hainan Province ,
Hainan Office Of China Banking ,
Chinese Urological Association Guideline ,
Prnewswire Asieris Pharmaceuticals ,
Asieris Pharmaceuticals ,
National Medical Products Administration ,
Insurance Regulatory Commission ,
Global Specialty Drug Insurance ,
Hainan Office ,
China Banking ,
Medical Security Bureau ,
Chinese Urological Association ,
Hainan Province ,
Hainan General Hospital ,
Specialty Drug ,
Vice President ,
Asieris ,
vimarsana.com © 2020. All Rights Reserved.